{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:37:52Z","timestamp":1768775872761,"version":"3.49.0"},"reference-count":62,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2023,12,8]]},"DOI":"10.1167\/tvst.12.12.10","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T17:30:47Z","timestamp":1702056647000},"page":"10","source":"Crossref","is-referenced-by-count":3,"title":["Minocycline and Diacetyl Minocycline Eye Drops Reduce Ocular Neovascularization in Mice"],"prefix":"10.1167","volume":"12","author":[{"given":"Joshua O.","family":"Willms","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayank","family":"Shashtri","sequence":"additional","affiliation":[{"name":"AttachChem, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Sundin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praneetha","family":"Panthagani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phat","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephany","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colton","family":"Sniegowski","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul A.","family":"Shaik","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristin","family":"Chaudhury","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted W.","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Bergeson","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"issue":"7070","key":"bib1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nature04482","article-title":"Retinal angiogenesis in development and disease","volume":"438","author":"Gariano","year":"2005","journal-title":"Nature"},{"issue":"9","key":"bib2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0161-6420(86)33609-1","article-title":"Choroidal neovascularization","volume":"93","author":"Green","year":"1986","journal-title":"Ophthalmology"},{"issue":"3","key":"bib3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2003.09.042","article-title":"Choroidal neovascularization","volume":"137","author":"Grossniklaus","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"bib4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/jcp.v213:2","article-title":"Seeing the light: new insights into the molecular pathogenesis of retinal diseases","volume":"213","author":"Campochiaro","year":"2007","journal-title":"J Cell Physiol"},{"issue":"2","key":"bib5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1167\/iovs.05-1494","article-title":"Ocular versus extraocular neovascularization: mirror images or vague resemblances","volume":"47","author":"Campochiaro","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"bib6","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/ijms19010110","article-title":"The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration","volume":"19","author":"Altmann","year":"2018","journal-title":"Int J Mol Sci"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"705783","DOI":"10.1155\/2014\/705783","article-title":"The role of microglia in diabetic retinopathy","volume":"2014","author":"Grigsby","year":"2014","journal-title":"J Ophthalmol"},{"issue":"4","key":"bib10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ajo.2007.06.025","article-title":"Age-related macular degeneration and the immune response: implications for therapy","volume":"144","author":"Nussenblatt","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"bib11","first-page":"2194","article-title":"Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes","volume":"39","author":"Steen","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"bib12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/bjo.2007.114769","article-title":"Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy","volume":"91","author":"Tatar","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"bib13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/archophthalmol.2007.65","article-title":"Microglial activation in human diabetic retinopathy","volume":"126","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"bib14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1017\/S0007114511004260","article-title":"Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"107","author":"Ma","year":"2012","journal-title":"Br J Nutr"},{"issue":"10153","key":"bib15","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"bib16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000322363","article-title":"A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration","volume":"225","author":"Sivaprasad","year":"2011","journal-title":"Ophthalmologica"},{"issue":"29\u201330","key":"bib17","first-page":"513","article-title":"The diagnosis and treatment of age-related macular degeneration","volume":"117","author":"Stahl","year":"2020","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"11","key":"bib18","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.ophtha.2014.05.022","article-title":"Systemic vascular safety of ranibizumab for age-related macular degeneration: systematic review and meta-analysis of randomized trials","volume":"121","author":"Ueta","year":"2014","journal-title":"Ophthalmology"},{"issue":"11","key":"bib19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamaophthalmol.2018.3578","article-title":"Loss to follow-up among patients with neovascular age-related macular degeneration who received intravitreal anti\u2013vascular endothelial growth factor injections","volume":"136","author":"Obeid","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"bib20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.oret.2017.12.006","article-title":"Medicare spending on anti\u2013vascular endothelial growth factor medications","volume":"2","author":"Patel","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.abb.2013.12.023","article-title":"Minocycline inhibits angiogenesis in vitro through the translational suppression of HIF-1a","volume":"545","author":"Jung","year":"2014","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"bib22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neuint.2006.10.008","article-title":"Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration","volume":"50","author":"Yao","year":"2007","journal-title":"Neurochem Int"},{"issue":"4","key":"bib23","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.3892\/mmr.2015.4064","article-title":"Minocycline inhibits PARP-1 expression and decreases apoptosis in diabetic retinopathy","volume":"12","author":"Wu","year":"2015","journal-title":"Mol Med Rep"},{"issue":"1","key":"bib24","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1038\/s41598-017-07978-z","article-title":"Impact of minocycline on vascularization and visual function in an immature mouse model of ischemic retinopathy","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"bib25","doi-asserted-by":"publisher","first-page":"e41858","DOI":"10.1371\/journal.pone.0041858","article-title":"Minocycline inhibits alkali burn-induced corneal neovascularization in mice","volume":"7","author":"Xiao","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"bib26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.2013.169.issue-2","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"2","key":"bib27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","volume":"196","author":"Kim","year":"2009","journal-title":"Behav Brain Res"},{"issue":"4","key":"bib28","first-page":"308","article-title":"Minocycline as a neuroprotective agent","volume":"11","author":"Stirling","year":"2005","journal-title":"Neurosci Rev J Bringing Neurobiol Neurol Psychiatry"},{"issue":"7","key":"bib29","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1167\/iovs.11-9413","article-title":"Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I\/II clinical study","volume":"53","author":"Cukras","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib30","first-page":"23","article-title":"Oral doxycycline reduces the total number of intraocular bevacizumab injections needed to control neovascular age-related macular degeneration","volume":"6","author":"Mirshahi","year":"2017","journal-title":"Med Hypothesis Discov Innov Ophthalmol J"},{"issue":"3","key":"bib31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.ajpath.2011.05.042","article-title":"Minocycline attenuates photoreceptor degeneration in a mouse model of subretinal hemorrhage","volume":"179","author":"Zhao","year":"2011","journal-title":"Am J Pathol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.exer.2018.06.030","article-title":"Mechanism of fibrosis inhibition in laser induced choroidal neovascularization by doxycycline","volume":"176","author":"Peng","year":"2018","journal-title":"Exp Eye Res"},{"issue":"12","key":"bib33","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1074\/jbc.M113.535765","article-title":"Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization","volume":"289","author":"He","year":"2014","journal-title":"J Biol Chem"},{"issue":"11","key":"bib34","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1167\/iovs.08-3174","article-title":"Doxycycline-mediated inhibition of choroidal neovascularization","volume":"50","author":"Samtani","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib35","first-page":"460","article-title":"Safety evaluation and pharmacodynamics of minocycline hydrochloride eye drops","volume":"28","author":"Li","year":"2022","journal-title":"Mol Vis"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0556-9","article-title":"Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner","volume":"9","author":"Schmidtner","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"2","key":"bib37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"bib38","first-page":"1","article-title":"Minocycline-induced microbiome alterations predict cafeteria diet-induced spatial recognition memory impairments in rats","volume":"10","author":"Leigh","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"12","key":"bib39","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1167\/iovs.06-0156","article-title":"A novel imaging technique for experimental choroidal neovascularization","volume":"47","author":"Campos","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"bib40","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ophtha.2010.01.037","article-title":"Doxycycline's effect on ocular angiogenesis: an in vivo analysis","volume":"117","author":"Cox","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"bib41","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1167\/iovs.11-9095","article-title":"Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist","volume":"54","author":"Mizutani","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"suppl 19","key":"bib42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0036-46652015000700011","article-title":"Susceptibility test for fungi: clinical and laboratorial correlations in medical mycology","volume":"57","author":"Alastruey-Izquierdo","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"bib43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.patbio.2010.07.020","article-title":"Comparison of the Sensititre YeastOne dilution method with the Clinical Laboratory Standards Institute (CLSI) M27-A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains","volume":"59","author":"Bertout","year":"2011","journal-title":"Pathol Biol (Paris)"},{"issue":"2","key":"bib46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00011-016-1002-6","article-title":"Activation of the TXNIP\/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline","volume":"66","author":"Chen","year":"2017","journal-title":"Inflamm Res"},{"issue":"5","key":"bib47","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Diabetes"},{"issue":"23","key":"bib48","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/sj.gt.3303034","article-title":"Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases","volume":"14","author":"Stieger","year":"2007","journal-title":"Gene Ther"},{"issue":"5","key":"bib49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamaophthalmol.2014.93","article-title":"Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non\u2013high-risk proliferative diabetic retinopathy: a randomized clinical trial","volume":"132","author":"Scott","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"bib50","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamaophthalmol.2014.1422","article-title":"Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial","volume":"132","author":"Scott","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"bib51","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"bib52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21307\/ane-2017-033","article-title":"Energy-dense diet triggers changes in gut microbiota, reorganization of gut-brain vagal communication and increases body fat accumulation","volume":"77","author":"Vaughn","year":"2017","journal-title":"Acta Neurobiol Exp (Warsz)"},{"issue":"11","key":"bib53","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2146\/ajhp160248","article-title":"Boto-de-los-Bueis A. Intraocular minocycline for the treatment of ocular pythiosis","volume":"74","author":"Ros Castellar","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"bib54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3109\/15569527.2015.1081604","article-title":"Determination of the toxicity of intravitreal minocycline in rabbit eyes","volume":"35","author":"Falavarjani","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"bib55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1179\/1120009X12Z.00000000018","article-title":"Intravitreal tigecycline treatment in experimental Acinetobacter baumannii endophthalmitis","volume":"24","author":"Horozoglu","year":"2012","journal-title":"J Chemother Florence Italy"},{"issue":"11","key":"bib56","doi-asserted-by":"publisher","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on M\u00fcller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PloS One"},{"issue":"1","key":"bib57","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.nano.2012.03.004","article-title":"Nanoliposomal minocycline for ocular drug delivery","volume":"9","author":"Kaiser","year":"2013","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"108476","DOI":"10.1016\/j.exer.2021.108476","article-title":"Microbes of the human eye: microbiome, antimicrobial resistance and biofilm formation","volume":"205","author":"Ranjith","year":"2021","journal-title":"Exp Eye Res"},{"issue":"1","key":"bib59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/aos.v99.1","article-title":"Current knowledge on the human eye microbiome: a systematic review of available amplicon and metagenomic sequencing data","volume":"99","author":"Delbeke","year":"2021","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"11","key":"bib60","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"bib61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/108076801753162807","article-title":"Practical issues in intravitreal drug delivery","volume":"17","author":"Maurice","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4236\/ojoph.2014.41005","article-title":"Aqueous interleukin-6 (IL-6) level is a marker for treatment resistance to bevacizumab in age-related macular degeneration\u2014aqueous cytokines after bevacizumab","volume":"2014","author":"Chalam","year":"2014","journal-title":"Open J Ophthalmol"},{"key":"bib9","first-page":"67","article-title":"Regulation of matrix metalloproteinase in the pathogenesis of diabetic retinopathy","volume-title":"Progress in Molecular Biology and Translational Science. Vol. 148. Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy","author":"Kowluru","year":"2017"},{"key":"bib44","volume-title":"Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standards","author":"Patel","year":"2015","edition":"12th ed."},{"key":"bib45","volume-title":"Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline","author":"Ghannoum","year":"2009","edition":"2nd ed."}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2793092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T17:31:00Z","timestamp":1702056660000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2793092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.12.12.10","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,8]]}}}